Literature DB >> 16770986

Oncologic emergencies: diagnosis and treatment.

Thorvardur R Halfdanarson1, William J Hogan, Timothy J Moynihan.   

Abstract

Patients with malignancies are subject to developing a unique set of complications that require emergent evaluation and treatment. With the increasing incidence of cancer in the general population and improved survival, these emergencies will be more frequently encountered. Physicians must be able to recognize these conditions and institute appropriate therapy after a focused initial evaluation. The approach to definitive therapy is commonly multidisciplinary, involving surgeons, radiation oncologists, medical oncologists, and other medical specialists. Prompt interventions can be lifesaving and may spare patients considerable morbidity and pain. In this review, we discuss the diagnosis of and initial therapy for common emergencies in hematology and oncology.

Entities:  

Mesh:

Year:  2006        PMID: 16770986     DOI: 10.4065/81.6.835

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  5 in total

1.  A child presenting with hypercalcemia.

Authors:  Emre Çelik; Gül Nihal Özdemir; Gülen Tüysüz; Yücel Taştan; Halit Çam; Tiraje Celkan
Journal:  Turk Pediatri Ars       Date:  2014-03-01

Review 2.  Oncologic Emergencies-The Old, the New, and the Deadly.

Authors:  Krishna Thandra; Zuhair Salah; Sanjay Chawla
Journal:  J Intensive Care Med       Date:  2018-11-09       Impact factor: 3.510

Review 3.  Neurological complications.

Authors:  Meng Law
Journal:  Cancer Imaging       Date:  2009-10-02       Impact factor: 3.909

4.  Prognostic relevance of pericardial effusion in patients with malignant diseases.

Authors:  Tae-Dong Jeong; Seongsoo Jang; Chan-Jeoung Park; Hyun-Sook Chi
Journal:  Korean J Hematol       Date:  2012-09-25

Review 5.  MDCT of abdominopelvic oncologic emergencies.

Authors:  Sree Harsha Tirumani; Vijayanadh Ojili; Gowthaman Gunabushanam; Kedar N Chintapalli; John G Ryan; Caroline Reinhold
Journal:  Cancer Imaging       Date:  2013-07-22       Impact factor: 3.909

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.